{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer resistance", "chemoprotection", "chemotherapy adjuvant", "rosmarinic acid"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39062581", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["867", "10.3390/biom14070867"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "19"}], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "14", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "19"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity.", "Abstract": {"AbstractText": ["Chemotherapeutic drugs and radiotherapy are fundamental treatments to combat cancer, but, often, the doses in these treatments are restricted by their non-selective toxicities, which affect healthy tissues surrounding tumors. On the other hand, drug resistance is recognized as the main cause of chemotherapeutic treatment failure. Rosmarinic acid (RA) is a polyphenol of the phenylpropanoid family that is widely distributed in plants and vegetables, including medicinal aromatic herbs, consumption of which has demonstrated beneficial activities as antioxidants and anti-inflammatories and reduced the risks of cancers. Recently, several studies have shown that RA is able to reverse cancer resistance to first-line chemotherapeutics, as well as play a protective role against toxicity induced by chemotherapy and radiotherapy, mainly due to its scavenger capacity. This review compiles information from 56 articles from Google Scholar, PubMed, and ClinicalTrials.gov aimed at addressing the role of RA as a complementary therapy in cancer treatment."]}, "AuthorList": [{"Identifier": ["0000-0002-9066-1763"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile."}], "LastName": "Villegas", "ForeName": "Cecilia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile."}], "LastName": "Cortez", "ForeName": "Nicole", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile."}, {"Identifier": [], "Affiliation": "Department of Chemistry and Industrial Chemistry, Kwara State University, Malete 1530, Nigeria."}], "LastName": "Ogundele", "ForeName": "Ayorinde Victor", "Initials": "AV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias Biol\u00f3gicas y Qu\u00edmicas, Facultad de Recursos Naturales, Universidad Cat\u00f3lica de Temuco, Rudecindo Ortega, Temuco 4780000, Chile."}], "LastName": "Burgos", "ForeName": "Viviana", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro Universitario ENIAC, Guarulhos 07012-030, SP, Brazil."}], "LastName": "Pardi", "ForeName": "Paulo Celso", "Initials": "PC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Qu\u00edmica Aplicada y Sustentable, Departamento de Qu\u00edmica, Facultad de Ciencias, Universidad de Tarapac\u00e1, Arica 1000000, Chile."}], "LastName": "Cabrera-Pardo", "ForeName": "Jaime R", "Initials": "JR"}, {"Identifier": ["0000-0002-4668-4984"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile."}], "LastName": "Paz", "ForeName": "Cristian", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "MQE6XG29YI", "NameOfSubstance": "Rosmarinic Acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Depsides"}, {"RegistryNumber": "0", "NameOfSubstance": "Cinnamates"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rosmarinic Acid"}, {"QualifierName": ["pharmacology", "chemistry", "therapeutic use"], "DescriptorName": "Depsides"}, {"QualifierName": ["pharmacology", "therapeutic use", "chemistry"], "DescriptorName": "Cinnamates"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gatti L., Zunino F. Overview of Tumor Cell Chemoresistance Mechanisms. In: Blumenthal R.D., editor. Chemosensitivity: Volume II: In VIVO Models, Imaging, and Molecular Regulators. Humana Press; Totowa, NJ, USA: 2005. pp. 127\u2013148.", "ArticleIdList": ["15911977"]}, {"Citation": "Nikolaou M., Pavlopoulou A., Georgakilas A.G., Kyrodimos E. The challenge of drug resistance in cancer treatment: A current overview. Clin. Exp. Metastasis. 2018;35:309\u2013318. doi: 10.1007/s10585-018-9903-0.", "ArticleIdList": ["10.1007/s10585-018-9903-0", "29799080"]}, {"Citation": "Al-Lazikani B., Banerji U., Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat. Biotechnol. 2012;30:679\u2013692. doi: 10.1038/nbt.2284.", "ArticleIdList": ["10.1038/nbt.2284", "22781697"]}, {"Citation": "Rahman M.A., Hannan M.A., Dash R., Rahman M.H., Islam R., Uddin M.J., Sohag A.A.M., Rahman M.H., Rhim H. Phytochemicals as a Complement to Cancer Chemotherapy: Pharmacological Modulation of the Autophagy-Apoptosis Pathway. Front. Pharmacol. 2021;12:639628. doi: 10.3389/fphar.2021.639628.", "ArticleIdList": ["10.3389/fphar.2021.639628", "PMC8138161", "34025409"]}, {"Citation": "Choudhari A.S., Mandave P.C., Deshpande M., Ranjekar P., Prakash O. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front. Pharmacol. 2019;10:1614.", "ArticleIdList": ["PMC7025531", "32116665"]}, {"Citation": "Sotiropoulou P.A., Christodoulou M.S., Silvani A., Herold-Mende C., Passarella D. Chemical approaches to targeting drug resistance in cancer stem cells. Drug Discov. Today. 2014;19:1547\u20131562. doi: 10.1016/j.drudis.2014.05.002.", "ArticleIdList": ["10.1016/j.drudis.2014.05.002", "24819719"]}, {"Citation": "Wang P., Yang H.L., Yang Y.J., Wang L., Lee S.C. Overcome Cancer Cell Drug Resistance Using Natural Products. Evid. Based Complement. Altern. Med. 2015;2015:767136. doi: 10.1155/2015/767136.", "ArticleIdList": ["10.1155/2015/767136", "PMC4569777", "26421052"]}, {"Citation": "Hussain S.A., Sulaiman A.A., Balch C., Chauhan H., Alhadidi Q.M., Tiwari A.K. Natural Polyphenols in Cancer Chemoresistance. Nutr. Cancer. 2016;68:879\u2013891. doi: 10.1080/01635581.2016.1192201.", "ArticleIdList": ["10.1080/01635581.2016.1192201", "27366999"]}, {"Citation": "de Oliveira J\u00fanior R.G., Christiane Adrielly A.F., da Silva Almeida J.R.G., Grougnet R., Thi\u00e9ry V., Picot L. Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms. Fitoterapia. 2018;129:383\u2013400. doi: 10.1016/j.fitote.2018.02.025.", "ArticleIdList": ["10.1016/j.fitote.2018.02.025", "29476786"]}, {"Citation": "Liao X.Z., Gao Y., Sun L.L., Liu J.H., Chen H.R., Yu L., Chen Z.Z., Chen W.H., Lin L.Z. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway. Phytother. Res. 2020;34:1142\u20131153. doi: 10.1002/ptr.6584.", "ArticleIdList": ["10.1002/ptr.6584", "PMC7217221", "31985119"]}, {"Citation": "Lim S.H., Nam K.H., Kim K., Yi S.A., Lee J., Han J.W. Rosmarinic Acid Methyl Ester Regulates Ovarian Cancer Cell Migration and Reverses Cisplatin Resistance by Inhibiting the Expression of Forkhead Box M1. Pharmaceuticals. 2020;13:302. doi: 10.3390/ph13100302.", "ArticleIdList": ["10.3390/ph13100302", "PMC7601071", "33053721"]}, {"Citation": "Li F.R., Fu Y.Y., Jiang D.H., Wu Z., Zhou Y.J., Guo L., Dong Z.M., Wang Z.Z. Reversal effect of rosmarinic acid on multidrug resistance in SGC7901/Adr cell. J. Asian Nat. Prod. Res. 2013;15:276\u2013285. doi: 10.1080/10286020.2012.762910.", "ArticleIdList": ["10.1080/10286020.2012.762910", "23421517"]}, {"Citation": "Yu C., Chen D.Q., Liu H.X., Li W.B., Lu J.W., Feng J.F. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p. Biomed. Pharmacother. 2019;109:2327\u20132334. doi: 10.1016/j.biopha.2018.10.061.", "ArticleIdList": ["10.1016/j.biopha.2018.10.061", "30551491"]}, {"Citation": "Nadeem M., Imran M., Aslam Gondal T., Imran A., Shahbaz M., Muhammad Amir R., Wasim Sajid M., Batool Qaisrani T., Atif M., Hussain G., et al. Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review. Appl. Sci. 2019;9:3139. doi: 10.3390/app9153139.", "ArticleIdList": ["10.3390/app9153139"]}, {"Citation": "Mu\u00f1oz-Mu\u00f1oz J.L., Garcia-Molina F., Ros E., Tudela J., Garc\u00cdA-Canovas F., Rodriguez-Lopez J.N. Prooxidant and antioxidant activities of rosmarinic acid. J. Food Biochem. 2013;37:396\u2013408. doi: 10.1111/j.1745-4514.2011.00639.x.", "ArticleIdList": ["10.1111/j.1745-4514.2011.00639.x"]}, {"Citation": "Amoah S.K., Sandjo L.P., Kratz J.M., Biavatti M.W. Rosmarinic Acid\u2013Pharmaceutical and Clinical Aspects. Planta Med. 2016;82:388\u2013406. doi: 10.1055/s-0035-1568274.", "ArticleIdList": ["10.1055/s-0035-1568274", "26845712"]}, {"Citation": "Zinsmeister H.D., Becker H., Eicher T. Bryophytes, a Source of Biologically Active, Naturally Occurring Material? Angew. Chem. Int. Ed. Engl. 1991;30:130\u2013147. doi: 10.1002/anie.199101301.", "ArticleIdList": ["10.1002/anie.199101301"]}, {"Citation": "Eicher T., Ott M., Speicher A. Bryophyte Constituents; 7: New Synthesis of (+)-Rosmarinic Acid and Related Compounds. Synthesis. 1996;1996:755\u2013762. doi: 10.1055/s-1996-4289.", "ArticleIdList": ["10.1055/s-1996-4289"]}, {"Citation": "Yuan H., Dan L., Sun Q.-Y., Han W. Total Synthesis of (\u00b1)-Rosmarinic Acid. Acta Chim. Sin. 2011;69:945."}, {"Citation": "Basu A., Bhattacharjee A., Bhattacharya S. Chemoprotectants in Cancer Chemotherapy: An Update. Biomed. Res. J. 2016;3:157\u2013181."}, {"Citation": "Dobrek \u0141., Thor P.J. Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention. Postepy Hig. Med. Dosw. 2012;66:592\u2013602. doi: 10.5604/17322693.1009703.", "ArticleIdList": ["10.5604/17322693.1009703", "23001201"]}, {"Citation": "Xiao Q., Zhu W., Feng W., Lee S.S., Leung A.W., Shen J., Gao L., Xu C. A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy. Front. Pharmacol. 2018;9:1534. doi: 10.3389/fphar.2018.01534.", "ArticleIdList": ["10.3389/fphar.2018.01534", "PMC6333683", "30687096"]}, {"Citation": "Jena G., Vikram A., Tripathi D.N., Ramarao P. Use of chemoprotectants in chemotherapy and radiation therapy: The challenges of selecting an appropriate agent. Integr. Cancer Ther. 2010;9:253\u2013258. doi: 10.1177/1534735410376633.", "ArticleIdList": ["10.1177/1534735410376633", "20702492"]}, {"Citation": "Colica C., Di Renzo L., Aiello V., De Lorenzo A., Abenavoli L. Rosmarinic Acid as Potential Anti-Inflammatory Agent. Rev. Recent Clin. Trials. 2018;13:240\u2013242. doi: 10.2174/157488711304180911095818.", "ArticleIdList": ["10.2174/157488711304180911095818", "30328397"]}, {"Citation": "Petersen M., Simmonds M.S. Rosmarinic acid. Phytochemistry. 2003;62:121\u2013125. doi: 10.1016/S0031-9422(02)00513-7.", "ArticleIdList": ["10.1016/S0031-9422(02)00513-7", "12482446"]}, {"Citation": "Petersen M., Abdullah Y., Benner J., Eberle D., Gehlen K., H\u00fccherig S., Janiak V., Kim K.H., Sander M., Weitzel C., et al. Evolution of rosmarinic acid biosynthesis. Phytochemistry. 2009;70:1663\u20131679. doi: 10.1016/j.phytochem.2009.05.010.", "ArticleIdList": ["10.1016/j.phytochem.2009.05.010", "19560175"]}, {"Citation": "Ijaz S., Iqbal J., Abbasi B.A., Ullah Z., Yaseen T., Kanwal S., Mahmood T., Sydykbayeva S., Ydyrys A., Almarhoon Z.M., et al. Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications. Biomed. Pharmacother. 2023;162:114687. doi: 10.1016/j.biopha.2023.114687.", "ArticleIdList": ["10.1016/j.biopha.2023.114687", "37062215"]}, {"Citation": "Pezeshki S., Petersen M. Rosmarinic Acid and Related Metabolites. In: Schwab W., Lange B.M., W\u00fcst M., editors. Biotechnology of Natural Products. Springer International Publishing; Cham, Switzerland: 2018. pp. 25\u201360."}, {"Citation": "Tr\u00f3cs\u00e1nyi E., Gy\u00f6rgy Z., Z\u00e1mborin\u00e9-N\u00e9meth \u00c9. New insights into rosmarinic acid biosynthesis based on molecular studies. Curr. Plant Biol. 2020;23:100162. doi: 10.1016/j.cpb.2020.100162.", "ArticleIdList": ["10.1016/j.cpb.2020.100162"]}, {"Citation": "Rita I., Pereira C., Barros L., Santos-Buelga C., Ferreira I.C. Mentha spicata L. infusions as sources of antioxidant phenolic compounds: Emerging reserve lots with special harvest requirements. Food Funct. 2016;7:4188\u20134192. doi: 10.1039/C6FO00841K.", "ArticleIdList": ["10.1039/C6FO00841K", "27604823"]}, {"Citation": "Shekarchi M., Hajimehdipoor H., Saeidnia S., Gohari A.R., Hamedani M.P. Comparative study of rosmarinic acid content in some plants of Labiatae family. Pharmacogn. Mag. 2012;8:37\u201341.", "ArticleIdList": ["PMC3307200", "22438661"]}, {"Citation": "Khojasteh A., Mirjalili M.H., Alcalde M.A., Cusido R.M., Eibl R., Palazon J. Powerful Plant Antioxidants: A New Biosustainable Approach to the Production of Rosmarinic Acid. Antioxidants. 2020;9:1273. doi: 10.3390/antiox9121273.", "ArticleIdList": ["10.3390/antiox9121273", "PMC7765155", "33327619"]}, {"Citation": "Fraser C.M., Chapple C. The phenylpropanoid pathway in Arabidopsis. Arabidopsis Book. 2011;9:e0152. doi: 10.1199/tab.0152.", "ArticleIdList": ["10.1199/tab.0152", "PMC3268504", "22303276"]}, {"Citation": "Vogt T. Phenylpropanoid biosynthesis. Mol. Plant. 2010;3:2\u201320. doi: 10.1093/mp/ssp106.", "ArticleIdList": ["10.1093/mp/ssp106", "20035037"]}, {"Citation": "Kim G.D., Park Y.S., Jin Y.H., Park C.S. Production and applications of rosmarinic acid and structurally related compounds. Appl. Microbiol. Biotechnol. 2015;99:2083\u20132092. doi: 10.1007/s00253-015-6395-6.", "ArticleIdList": ["10.1007/s00253-015-6395-6", "25620368"]}, {"Citation": "Konishi Y., Hitomi Y., Yoshida M., Yoshioka E. Pharmacokinetic Study of Caffeic and Rosmarinic Acids in Rats after Oral Administration. J. Agric. Food Chem. 2005;53:4740\u20134746. doi: 10.1021/jf0478307.", "ArticleIdList": ["10.1021/jf0478307", "15941309"]}, {"Citation": "Nakazawa T., Ohsawa K. Metabolism of Rosmarinic Acid in Rats. J. Nat. Prod. 1998;61:993\u2013996. doi: 10.1021/np980072s.", "ArticleIdList": ["10.1021/np980072s", "9722482"]}, {"Citation": "Baba S., Osakabe N., Natsume M., Terao J. Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid. Life Sci. 2004;75:165\u2013178. doi: 10.1016/j.lfs.2003.11.028.", "ArticleIdList": ["10.1016/j.lfs.2003.11.028", "15120569"]}, {"Citation": "Baba S., Osakabe N., Natsume M., Yasuda A., Muto Y., Hiyoshi K., Takano H., Yoshikawa T., Terao J. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. Eur. J. Nutr. 2005;44:1\u20139. doi: 10.1007/s00394-004-0482-2.", "ArticleIdList": ["10.1007/s00394-004-0482-2", "15309457"]}, {"Citation": "Li P., Yang X., Lee W.J., Huang F., Wang Y., Li Y. Comparison between synthetic and rosemary-based antioxidants for the deep frying of French fries in refined soybean oils evaluated by chemical and non-destructive rapid methods. Food Chem. 2021;335:127638. doi: 10.1016/j.foodchem.2020.127638.", "ArticleIdList": ["10.1016/j.foodchem.2020.127638", "32736158"]}, {"Citation": "Choi S.H., Jang G.W., Choi S.I., Jung T.D., Cho B.Y., Sim W.S., Han X., Lee J.S., Kim D.Y., Kim D.B., et al. Development and Validation of an Analytical Method for Carnosol, Carnosic Acid and Rosmarinic Acid in Food Matrices and Evaluation of the Antioxidant Activity of Rosemary Extract as a Food Additive. Antioxidants. 2019;8:76. doi: 10.3390/antiox8030076.", "ArticleIdList": ["10.3390/antiox8030076", "PMC6466591", "30917571"]}, {"Citation": "Ge L., Zhu M., Li X., Xu Y., Ma X., Shi R., Li D., Mu C. Development of active rosmarinic acid-gelatin biodegradable films with antioxidant and long-term antibacterial activities. Food Hydrocoll. 2018;83:308\u2013316. doi: 10.1016/j.foodhyd.2018.04.052.", "ArticleIdList": ["10.1016/j.foodhyd.2018.04.052"]}, {"Citation": "Guitard R., Paul J.F., Nardello-Rataj V., Aubry J.M. Myricetin, rosmarinic and carnosic acids as superior natural antioxidant alternatives to \u03b1-tocopherol for the preservation of omega-3 oils. Food Chem. 2016;213:284\u2013295. doi: 10.1016/j.foodchem.2016.06.038.", "ArticleIdList": ["10.1016/j.foodchem.2016.06.038", "27451183"]}, {"Citation": "Mellor D.D., Hamer H., Smyth S., Atkin S.L., Courts F.L. Antioxidant-rich spice added to hamburger meat during cooking results in reduced meat, plasma, and urine malondialdehyde concentrations. Am. J. Clin. Nutr. 2010;92:996\u2013997. doi: 10.3945/ajcn.2010.29976.", "ArticleIdList": ["10.3945/ajcn.2010.29976", "20720254"]}, {"Citation": "Ferraro V., Madureira A.R., Sarmento B., Gomes A., Pintado M.E. Study of the interactions between rosmarinic acid and bovine milk whey protein \u03b1-Lactalbumin, \u03b2-Lactoglobulin and Lactoferrin. Food Res. Int. 2015;77:450\u2013459. doi: 10.1016/j.foodres.2015.08.024.", "ArticleIdList": ["10.1016/j.foodres.2015.08.024"]}, {"Citation": "Zhang B., Wang Q., Zhou P.P., Li N.N., Han S.Y. Copigmentation evidence of oenin with phenolic compounds: A comparative study of spectrographic, thermodynamic and theoretical data. Food Chem. 2020;313:126163. doi: 10.1016/j.foodchem.2020.126163.", "ArticleIdList": ["10.1016/j.foodchem.2020.126163", "31945702"]}, {"Citation": "Kovatcheva-Apostolova E.G., Georgiev M.I., Ilieva M.P., Skibsted L.H., R\u00f8dtjer A., Andersen M.L. Extracts of plant cell cultures of Lavandula vera and Rosa damascena as sources of phenolic antioxidants for use in foods. Eur. Food Res. Technol. 2008;227:1243\u20131249. doi: 10.1007/s00217-008-0842-x.", "ArticleIdList": ["10.1007/s00217-008-0842-x"]}, {"Citation": "Klisurova D., Petrova I., Ognyanov M., Georgiev Y., Kratchanova M., Denev P. Co-pigmentation of black chokeberry (Aronia melanocarpa) anthocyanins with phenolic co-pigments and herbal extracts. Food Chem. 2019;279:162\u2013170. doi: 10.1016/j.foodchem.2018.11.125.", "ArticleIdList": ["10.1016/j.foodchem.2018.11.125", "30611475"]}, {"Citation": "Zheng H.C. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8:59950\u201359964. doi: 10.18632/oncotarget.19048.", "ArticleIdList": ["10.18632/oncotarget.19048", "PMC5601792", "28938696"]}, {"Citation": "Wang X., Zhang H., Chen X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2019;2:141\u2013160. doi: 10.20517/cdr.2019.10.", "ArticleIdList": ["10.20517/cdr.2019.10", "PMC8315569", "34322663"]}, {"Citation": "Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 2005;5:275\u2013284. doi: 10.1038/nrc1590.", "ArticleIdList": ["10.1038/nrc1590", "15803154"]}, {"Citation": "Holohan C., Van Schaeybroeck S., Longley D.B., Johnston P.G. Cancer drug resistance: An evolving paradigm. Nat. Rev. Cancer. 2013;13:714\u2013726. doi: 10.1038/nrc3599.", "ArticleIdList": ["10.1038/nrc3599", "24060863"]}, {"Citation": "Housman G., Byler S., Heerboth S., Lapinska K., Longacre M., Snyder N., Sarkar S. Drug resistance in cancer: An overview. Cancers. 2014;6:1769\u20131792. doi: 10.3390/cancers6031769.", "ArticleIdList": ["10.3390/cancers6031769", "PMC4190567", "25198391"]}, {"Citation": "Ramos A., Sadeghi S., Tabatabaeian H. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them. Int. J. Mol. Sci. 2021;22:9451. doi: 10.3390/ijms22179451.", "ArticleIdList": ["10.3390/ijms22179451", "PMC8430957", "34502361"]}, {"Citation": "Li H., Zhang Y., Chen H.-H., Huang E., Zhuang H., Li D., Ni F. Rosmarinic acid inhibits stem-like breast cancer through hedgehog and Bcl-2/Bax signaling pathways. Pharmacogn. Mag. 2019;15:600\u2013606. doi: 10.4103/pm.pm_22_19.", "ArticleIdList": ["10.4103/pm.pm_22_19"]}, {"Citation": "Steinbichler T.B., Dud\u00e1s J., Skvortsov S., Ganswindt U., Riechelmann H., Skvortsova I.I. Therapy resistance mediated by cancer stem cells. Semin. Cancer Biol. 2018;53:156\u2013167. doi: 10.1016/j.semcancer.2018.11.006.", "ArticleIdList": ["10.1016/j.semcancer.2018.11.006", "30471331"]}, {"Citation": "Torre L.A., Trabert B., DeSantis C.E., Miller K.D., Samimi G., Runowicz C.D., Gaudet M.M., Jemal A., Siegel R.L. Ovarian cancer statistics, 2018. CA Cancer J. Clin. 2018;68:284\u2013296. doi: 10.3322/caac.21456.", "ArticleIdList": ["10.3322/caac.21456", "PMC6621554", "29809280"]}, {"Citation": "Orditura M., Galizia G., Sforza V., Gambardella V., Fabozzi A., Laterza M.M., Andreozzi F., Ventriglia J., Savastano B., Mabilia A., et al. Treatment of gastric cancer. World J. Gastroenterol. 2014;20:1635\u20131649. doi: 10.3748/wjg.v20.i7.1635.", "ArticleIdList": ["10.3748/wjg.v20.i7.1635", "PMC3930964", "24587643"]}, {"Citation": "Yu B., Gu D., Zhang X., Liu B., Xie J. The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer. J. Genet. Genom. 2017;44:375\u2013383. doi: 10.1016/j.jgg.2017.04.008.", "ArticleIdList": ["10.1016/j.jgg.2017.04.008", "PMC5604254", "28847472"]}, {"Citation": "Ajani J.A., D'Amico T.A., Bentrem D.J., Chao J., Cooke D., Corvera C., Das P., Enzinger P.C., Enzler T., Fanta P., et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 2022;20:167\u2013192. doi: 10.6004/jnccn.2022.0008.", "ArticleIdList": ["10.6004/jnccn.2022.0008", "35130500"]}, {"Citation": "Zhang Q., Wang C., Han X., Yang G., Ge Z., Zhang G. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation. Biochem. Biophys. Res. Commun. 2018;503:2333\u20132339. doi: 10.1016/j.bbrc.2018.06.158.", "ArticleIdList": ["10.1016/j.bbrc.2018.06.158", "29964008"]}, {"Citation": "Huang L., Chen J., Quan J., Xiang D. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3\u03b2 axis. Bioengineered. 2021;12:3065\u20133076. doi: 10.1080/21655979.2021.1941699.", "ArticleIdList": ["10.1080/21655979.2021.1941699", "PMC8806498", "34224305"]}, {"Citation": "Sharma A., Bender S., Zimmermann M., Riesterer O., Broggini-Tenzer A., Pruschy M.N. Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer. Clin. Cancer Res. 2016;22:4428\u20134439. doi: 10.1158/1078-0432.CCR-15-2449.", "ArticleIdList": ["10.1158/1078-0432.CCR-15-2449", "27076628"]}, {"Citation": "Chou S.T., Ho B.Y., Tai Y.T., Huang C.J., Chao W.W. Bidirect effects from cisplatin combine with rosmarinic acid (RA) or hot water extracts of Glechoma hederacea (HWG) on renal cancer cells. Chin. Med. 2020;15:77. doi: 10.1186/s13020-020-00358-2.", "ArticleIdList": ["10.1186/s13020-020-00358-2", "PMC7391823", "32760434"]}, {"Citation": "Wierstra I. The transcription factor FOXM1 (Forkhead box M1): Proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv. Cancer Res. 2013;118:97\u2013398.", "ArticleIdList": ["23768511"]}, {"Citation": "Nam K.H., Yi S.A., Nam G., Noh J.S., Park J.W., Lee M.G., Park J.H., Oh H., Lee J., Lee K.R., et al. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer. BMC Cancer. 2019;19:773. doi: 10.1186/s12885-019-5997-2.", "ArticleIdList": ["10.1186/s12885-019-5997-2", "PMC6683399", "31387554"]}, {"Citation": "Zeng Y., Zhang Q., Zhang Y., Lu M., Liu Y., Zheng T., Feng S., Hao M., Shi H. MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies. PLoS ONE. 2015;10:e0138049. doi: 10.1371/journal.pone.0138049.", "ArticleIdList": ["10.1371/journal.pone.0138049", "PMC4569423", "26367866"]}, {"Citation": "Bose M., Mukherjee P. Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers. Vaccines. 2020;8:659. doi: 10.3390/vaccines8040659.", "ArticleIdList": ["10.3390/vaccines8040659", "PMC7712407", "33167508"]}, {"Citation": "Radziejewska I., Supruniuk K., Bielawska A. Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells. Eur. J. Pharmacol. 2021;902:174119. doi: 10.1016/j.ejphar.2021.174119.", "ArticleIdList": ["10.1016/j.ejphar.2021.174119", "33930385"]}, {"Citation": "Saray E.A., Azadmard-Damirchi S., Gharekhani M. Combination therapy against breast cancer cells by docetaxel with rosmarinic and thymoquinone: An experimental study. Crescent J. Med. Biol. Sci. 2022;9:69"}, {"Citation": "Mahmoud M.A., Okda T.M., Omran G.A., Abd-Alhaseeb M.M. Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 \u03baB-p53-caspase-3 pathways modulation. J. Appl. Biomed. 2021;19:202\u2013209. doi: 10.32725/jab.2021.024.", "ArticleIdList": ["10.32725/jab.2021.024", "34907739"]}, {"Citation": "Ayala A., Mu\u00f1oz M.F., Arg\u00fcelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell Longev. 2014;2014:360438. doi: 10.1155/2014/360438.", "ArticleIdList": ["10.1155/2014/360438", "PMC4066722", "24999379"]}, {"Citation": "Mao C., Lei G., Horbath A., Gan B. Assessment of lipid peroxidation in irradiated cells. Methods Cell Biol. 2022;172:37\u201350.", "ArticleIdList": ["36064225"]}, {"Citation": "Koleini N., Nickel B.E., Edel A.L., Fandrich R.R., Ravandi A., Kardami E. Oxidized phospholipids in Doxorubicin-induced cardiotoxicity. Chem. Biol. Interact. 2019;303:35\u201339. doi: 10.1016/j.cbi.2019.01.032.", "ArticleIdList": ["10.1016/j.cbi.2019.01.032", "30707978"]}, {"Citation": "Eskandari M.R., Moghaddam F., Shahraki J., Pourahmad J. A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine. Xenobiotica. 2015;45:79\u201387. doi: 10.3109/00498254.2014.942809.", "ArticleIdList": ["10.3109/00498254.2014.942809", "25034007"]}, {"Citation": "Casares C., Ram\u00edrez-Camacho R., Trinidad A., Rold\u00e1n A., Jorge E., Garc\u00eda-Berrocal J.R. Reactive oxygen species in apoptosis induced by cisplatin: Review of physiopathological mechanisms in animal models. Eur. Arch. Otorhinolaryngol. 2012;269:2455\u20132459. doi: 10.1007/s00405-012-2029-0.", "ArticleIdList": ["10.1007/s00405-012-2029-0", "22584749"]}, {"Citation": "Chen J.H., Ho C.T. Antioxidant Activities of Caffeic Acid and Its Related Hydroxycinnamic Acid Compounds. J. Agric. Food Chem. 1997;45:2374\u20132378. doi: 10.1021/jf970055t.", "ArticleIdList": ["10.1021/jf970055t"]}, {"Citation": "Fadel O., El Kirat K., Morandat S. The natural antioxidant rosmarinic acid spontaneously penetrates membranes to inhibit lipid peroxidation in situ. Biochim. Biophys. Acta. 2011;1808:2973\u20132980. doi: 10.1016/j.bbamem.2011.08.011.", "ArticleIdList": ["10.1016/j.bbamem.2011.08.011", "21864504"]}, {"Citation": "Pugazhendhi A., Edison T., Velmurugan B.K., Jacob J.A., Karuppusamy I. Toxicity of Doxorubicin (Dox) to different experimental organ systems. Life Sci. 2018;200:26\u201330. doi: 10.1016/j.lfs.2018.03.023.", "ArticleIdList": ["10.1016/j.lfs.2018.03.023", "29534993"]}, {"Citation": "Carvalho C., Santos R.X., Cardoso S., Correia S., Oliveira P.J., Santos M.S., Moreira P.I. Doxorubicin: The good, the bad and the ugly effect. Curr. Med. Chem. 2009;16:3267\u20133285. doi: 10.2174/092986709788803312.", "ArticleIdList": ["10.2174/092986709788803312", "19548866"]}, {"Citation": "Zhang X., Zhu J.X., Ma Z.G., Wu H.M., Xu S.C., Song P., Kong C.Y., Yuan Y.P., Deng W., Tang Q.Z. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. Int. J. Biol. Sci. 2019;15:556\u2013567. doi: 10.7150/ijbs.29907.", "ArticleIdList": ["10.7150/ijbs.29907", "PMC6367577", "30745842"]}, {"Citation": "Kim D.S., Kim H.R., Woo E.R., Hong S.T., Chae H.J., Chae S.W. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem. Pharmacol. 2005;70:1066\u20131078. doi: 10.1016/j.bcp.2005.06.026.", "ArticleIdList": ["10.1016/j.bcp.2005.06.026", "16102732"]}, {"Citation": "Rahbardar M.G., Eisvand F., Rameshrad M., Razavi B.M., Hosseinzadeh H. In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity. Nutr. Cancer. 2022;74:747\u2013760. doi: 10.1080/01635581.2021.1931362.", "ArticleIdList": ["10.1080/01635581.2021.1931362", "34085575"]}, {"Citation": "Chlopc\u00edkov\u00e1 S., Psotov\u00e1 J., Miketov\u00e1 P., Sousek J., Lichnovsk\u00fd V., Sim\u00e1nek V. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. caffeic, chlorogenic and rosmarinic acids. Phytother. Res. 2004;18:408\u2013413. doi: 10.1002/ptr.1461.", "ArticleIdList": ["10.1002/ptr.1461", "15174003"]}, {"Citation": "Fern\u00e1ndez J., P\u00e9rez-\u00c1lvarez J.A., Fern\u00e1ndez-L\u00f3pez J.A. Thiobarbituric acid test for monitoring lipid oxidation in meat. Food Chem. 1997;59:345\u2013353. doi: 10.1016/S0308-8146(96)00114-8.", "ArticleIdList": ["10.1016/S0308-8146(96)00114-8"]}, {"Citation": "Das J., Vasan V., Sil P.C. Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicol. Appl. Pharmacol. 2012;258:296\u2013308. doi: 10.1016/j.taap.2011.11.009.", "ArticleIdList": ["10.1016/j.taap.2011.11.009", "22138235"]}, {"Citation": "Uyeturk U., Uyeturk U., Firat T., Cetinkaya A., Kin Tekce B., Cakir S. Protective effects of rosmarinic acid on doxorubicin-induced testicular damage. Chemotherapy. 2014;60:7\u201312. doi: 10.1159/000365727.", "ArticleIdList": ["10.1159/000365727", "25301265"]}, {"Citation": "Ahmed R., Abdella E. Modulatory Effects of Rosemary Leaves Aqueous Extract on Doxorubicin-Induced Histological Lesions, Apoptosis and Oxidative Stress in Mice. Int. J. Cancer Manag. 2010;3:e80651."}, {"Citation": "Hamza A.A., Ahmed M.M., Elwey H.M., Amin A. Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells. PLoS ONE. 2016;11:e0167049. doi: 10.1371/journal.pone.0167049.", "ArticleIdList": ["10.1371/journal.pone.0167049", "PMC5120835", "27880817"]}, {"Citation": "Fetoni A.R., Eramo S.L.M., Di Pino A., Rolesi R., Paciello F., Grassi C., Troiani D., Paludetti G. The Antioxidant Effect of Rosmarinic Acid by Different Delivery Routes in the Animal Model of Noise-Induced Hearing Loss. Otol. Neurotol. 2018;39:378\u2013386. doi: 10.1097/MAO.0000000000001700.", "ArticleIdList": ["10.1097/MAO.0000000000001700", "29424820"]}, {"Citation": "Chv\u00e1lov\u00e1 K., Brabec V., Kasp\u00e1rkov\u00e1 J. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res. 2007;35:1812\u20131821. doi: 10.1093/nar/gkm032.", "ArticleIdList": ["10.1093/nar/gkm032", "PMC1874601", "17329374"]}, {"Citation": "Berndtsson M., H\u00e4gg M., Panaretakis T., Havelka A.M., Shoshan M.C., Linder S. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int. J. Cancer. 2007;120:175\u2013180. doi: 10.1002/ijc.22132.", "ArticleIdList": ["10.1002/ijc.22132", "17044026"]}, {"Citation": "Badr N.M., McMurray J.L., Danial I., Hayward S., Asaad N.Y., Abd El-Wahed M.M., Abdou A.G., Serag El-Dien M.M., Sharma N., Horimoto Y., et al. Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex Immunofluorescence. Pathobiology. 2023;90:31\u201343. doi: 10.1159/000524549.", "ArticleIdList": ["10.1159/000524549", "35705026"]}, {"Citation": "Miller R.P., Tadagavadi R.K., Ramesh G., Reeves W.B. Mechanisms of Cisplatin nephrotoxicity. Toxins. 2010;2:2490\u20132518. doi: 10.3390/toxins2112490.", "ArticleIdList": ["10.3390/toxins2112490", "PMC3153174", "22069563"]}, {"Citation": "Giaccone G., Zatloukal P., Roubec J., Floor K., Musil J., Kuta M., van Klaveren R.J., Chaudhary S., Gunther A., Shamsili S. Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. J. Clin. Oncol. 2009;27:4481\u20134486. doi: 10.1200/JCO.2008.21.1862.", "ArticleIdList": ["10.1200/JCO.2008.21.1862", "19687333"]}, {"Citation": "Raviadaran R., Ng M.H., Chandran D., Ooi K.K., Manickam S. Stable W/O/W multiple nanoemulsion encapsulating natural tocotrienols and caffeic acid with cisplatin synergistically treated cancer cell lines (A549 and HEP G2) and reduced toxicity on normal cell line (HEK 293) Mater. Sci. Eng. C Mater. Biol. Appl. 2021;121:111808. doi: 10.1016/j.msec.2020.111808.", "ArticleIdList": ["10.1016/j.msec.2020.111808", "33579452"]}, {"Citation": "Domitrovi\u0107 R., Poto\u010dnjak I., Crn\u010devi\u0107-Orli\u0107 Z., \u0160koda M. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice. Food Chem. Toxicol. 2014;66:321\u2013328. doi: 10.1016/j.fct.2014.02.002.", "ArticleIdList": ["10.1016/j.fct.2014.02.002", "24518541"]}, {"Citation": "Jeong H.J., Choi Y., Kim M.H., Kang I.C., Lee J.H., Park C., Park R., Kim H.M. Rosmarinic acid, active component of Dansam-Eum attenuates ototoxicity of cochlear hair cells through blockage of caspase-1 activity. PLoS ONE. 2011;6:e18815. doi: 10.1371/journal.pone.0018815.", "ArticleIdList": ["10.1371/journal.pone.0018815", "PMC3078149", "21526214"]}, {"Citation": "Morgan S., Lopes F., Gourley C., Anderson R.A., Spears N. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLoS ONE. 2013;8:e70117. doi: 10.1371/journal.pone.0070117.", "ArticleIdList": ["10.1371/journal.pone.0070117", "PMC3726485", "23922929"]}, {"Citation": "Chang E.M., Lim E., Yoon S., Jeong K., Bae S., Lee D.R., Yoon T.K., Choi Y., Lee W.S. Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice. PLoS ONE. 2015;10:e0144245. doi: 10.1371/journal.pone.0144245.", "ArticleIdList": ["10.1371/journal.pone.0144245", "PMC4699462", "26656301"]}, {"Citation": "Gui H., Jin Y., Lin A., Wang P., Wang Y., Zhu H. Rosmarinic acid relieves cisplatin-induced ovary toxicity in female mice via suppression of oxidative stress and inflammation. J Biochem Mol Toxicol. 2021;35:e22839. doi: 10.1002/jbt.22839.", "ArticleIdList": ["10.1002/jbt.22839", "34250696"]}, {"Citation": "Stein A., Arnold D. Oxaliplatin: A review of approved uses. Expert. Opin. Pharmacother. 2012;13:125\u2013137. doi: 10.1517/14656566.2012.643870.", "ArticleIdList": ["10.1517/14656566.2012.643870", "22149372"]}, {"Citation": "Areti A., Komirishetty P., Kalvala A.K., Nellaiappan K., Kumar A. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy. Mol. Neurobiol. 2018;55:7463\u20137475. doi: 10.1007/s12035-018-0920-4.", "ArticleIdList": ["10.1007/s12035-018-0920-4", "29427084"]}, {"Citation": "Zhang T., Liu C., Ma S., Gao Y., Wang R. Protective Effect and Mechanism of Action of Rosmarinic Acid on Radiation-Induced Parotid Gland Injury in Rats. Dose Response. 2020;18:1559325820907782. doi: 10.1177/1559325820907782.", "ArticleIdList": ["10.1177/1559325820907782", "PMC7036515", "32127788"]}, {"Citation": "Lukmanul Hakkim F., Miura M., Matsuda N., Alharassi A.S., Guillemin G., Yamauchi M., Arivazhagan G., Song H. An in vitro evidence for caffeic acid, rosmarinic acid and trans cinnamic acid as a skin protectant against \u03b3-radiation. Int. J. Low Radiat. 2014;9:305\u2013316. doi: 10.1504/IJLR.2014.063414.", "ArticleIdList": ["10.1504/IJLR.2014.063414"]}]}], "History": [{"Year": "2024", "Month": "5", "Day": "13"}, {"Year": "2024", "Month": "7", "Day": "3"}, {"Year": "2024", "Month": "7", "Day": "9"}, {"Year": "2024", "Month": "7", "Day": "28", "Hour": "14", "Minute": "52"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "10", "Minute": "46"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "1", "Minute": "9"}, {"Year": "2024", "Month": "7", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["39062581", "PMC11274592", "10.3390/biom14070867", "biom14070867"]}}]}